000 01530 a2200409 4500
005 20250516182155.0
264 0 _c20140805
008 201408s 0 0 eng d
022 _a1873-264X
024 7 _a10.1016/j.jpba.2013.10.021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiu, Mingtao
245 0 0 _aHPLC method development, validation and impurity characterization for an antitumor Hsp90 inhibitor-PU-H71 (NSC 750424).
_h[electronic resource]
260 _bJournal of pharmaceutical and biomedical analysis
_cFeb 2014
300 _a34-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aBenzodioxoles
_xchemistry
650 0 4 _aChromatography, High Pressure Liquid
_xmethods
650 0 4 _aDrug Contamination
650 0 4 _aDrug Stability
650 0 4 _aHSP90 Heat-Shock Proteins
_xantagonists & inhibitors
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aMass Spectrometry
_xmethods
650 0 4 _aOxidation-Reduction
650 0 4 _aPhotolysis
650 0 4 _aPurines
_xchemistry
650 0 4 _aSensitivity and Specificity
700 1 _aWang, Jennie
700 1 _aWu, Xiaogang
700 1 _aWang, Euphemia
700 1 _aBaptista, Diego
700 1 _aScott, Brendan
700 1 _aLiu, Paul
773 0 _tJournal of pharmaceutical and biomedical analysis
_gvol. 89
_gp. 34-41
856 4 0 _uhttps://doi.org/10.1016/j.jpba.2013.10.021
_zAvailable from publisher's website
999 _c23285677
_d23285677